358 S MAIN ST, BURLINGTON, NC
To Announce First Quarter Financial Results on April 30, 2026
Labcorp Holdings Inc. Enters $750M Term Loan Credit Agreement
Announces 2025 Fourth Quarter and Full Year Results
Appoints John H. Sampson, M.D., Ph.D., to Board of Directors
Labcorp Holdings Inc. Enters Second Amendment to Receivables Purchase Agreement
To Announce Fourth Quarter Financial Results on February 17, 2026
Declares Quarterly Dividend
To Speak at the 44th Annual J.P. Morgan Healthcare Conference
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Suspension of Duty to File Reports
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
S-8 POS
Free Writing Prospectus